Charles River Labs (CRL) PT Lowered to $464 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Charles River Labs (CRL) PT Lowered to $400 at Citi
November 4, 2021 6:45 AM EDTCiti analyst Patrick Donnelly lowered the price target on Charles River Labs (NYSE: CRL) to $400.00 (from $425.00) while maintaining a Neutral rating.... More
Charles River Labs (CRL) PT Lowered to $465 at Morgan Stanley
November 4, 2021 4:04 AM EDTMorgan Stanley analyst Ricky Goldwasser lowered the price target on Charles River Labs (NYSE: CRL) to $465.00 (from $480.00) while maintaining a Overweight rating.... More
Charles River Labs (CRL) PT Lowered to $440 at Evercore ISI
November 3, 2021 4:05 PM EDTEvercore ISI analyst Elizabeth Anderson lowered the price target on Charles River Labs (NYSE: CRL) to $440.00 (from $460.00) while maintaining a Outperform rating.... More
Charles River Laboratories (CRL) Tops Q3 EPS by 12c, Updates Guidance
November 3, 2021 7:09 AM EDTCharles River Laboratories (NYSE: CRL) reported Q3 EPS of $2.70, $0.12 better than the analyst estimate of $2.58. Revenue for the quarter came in at $895.9 million versus the consensus estimate of $908.19 million.
GUIDANCE:
Charles River Laboratories sees FY2021 EPS of $10.20-$10.30, versus the consensus of... More
